Patent Yard Sign in
Expired Canadian patentCanada

Derivatives of indazole and the preparation thereof

CA 1082199 A · Owner: Boehringer Mannheim G.M.B.H. · Inventors: Wiedemann, Fritz; Kampe, Wolfgang

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

New derivatives of indazole and their preparation are provided of the formula (I):-, (I), wherein R1 is a hydrogen atom or a lower alkyl radical. R' is a hydrogen atom or an acyl radical and R2 is a benzyl radical or a radical of the formula:-, in which X is a reactive residue and Y is a hydroxyl group or X and Y together represent an oxygen atom and when R ' is an, acyl radical, R2 can also be a hydrogen atom the derivatives, have been found to be valuable intermediates for the preparation of useful, pharmacologically-active compounds for example, 3-indazolyl-(4)-oxy-propan-2-ol amines which can bring about an inhibition of adrenergic .beta.-receptors and can therefore, be, used for the …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted July 22, 1980. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 22, 1997.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 29, 1977
GrantedJuly 22, 1980
Term endedJuly 22, 1997
Patent numberCA 1082199 A
Classification (IPC)C07D231/56

Timeline

Timeline From CIPO dates

1978198019821984198619881990199219941996Application filedApril 29, 1977Patent grantedJuly 22, 1980Term endedJuly 22, 1997

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.